RECRUITING

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The researchers will conduct 'Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)', which also utilizes MOST, and the same 4 obesity intervention components as in SANOS, but targets the overweight/obesity crisis in another at-risk, low socioeconomic status (SES) population, taxi and for-hire vehicle (FHV) drivers (Lyft, Uber, etc.). ROADMAP also utilizes an effectiveness- implementation hybrid type 1 design. Hybrid trials, which blend effectiveness and implementation studies, can lead to more rapid translational uptake and more effective implementation. Taxi and FHV drivers are a growing, multilingual, hard-to-reach, predominantly immigrant and minority essential worker population. There are over 750,000 licensed taxi and FHV drivers in in the U.S. and over 185,000 in New York City (NYC). They have higher rates of overweight/obese range body mass index (BMI) than New Yorkers in general (77% vs 56%) and have high rates of elevated waist circumference, sedentary behavior, poor diets, and health care services underutilization. ROADmAP will test 4 evidence- and theory-based (Social Cognitive Theory \[SCT\]) behavior change intervention components. We will use MOST to identify which of the 4 components contribute most significantly and cost-effectively to weight loss among NYC drivers recruited at workplace health fairs (HFs) and virtually. Objectives are to apply MOST to design an optimized version of a scalable, lifestyle intervention for taxi/FHV drivers, and then to conduct a mixed methods multistakeholder process evaluation to facilitate widespread intervention implementation.

Official Title

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

Quick Facts

Study Start:2022-12-22
Study Completion:2026-08-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05770570

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Self-Identifies as Mexican American or Mexican
  2. * Seeking services at the VDS of the Mexican Consulate
  3. * Prefers to speak in Spanish
  4. * All adults at least 18 years of age
  5. * Screens as obese (an adult who has a Body Mass Index (BMI) 30 or higher) or overweight (an adult who has a BMI between 25 - 29.9)
  6. * Agrees to be audio recorded
  7. * Self-identifies as Hispanic/Latino;
  8. * Seeking services at VDS or VDS Mobile;
  9. * Prefers to speak in Spanish;
  10. * At least 18 years of age;
  11. * Screens as obese (BMI ≥ 30 kg/m\^2) or overweight (BMI of 25 - 29.9 kg/m\^2);
  12. * Agrees to be audio recorded
  13. * Self-identifies as Hispanic/Latino;
  14. * Seeking services at VDS or VDS Mobile;
  15. * Prefers to speak in Spanish;
  16. * At least 18 years of age;
  17. * Screens as obese (BMI ≥ 30 kg/m\^2) or overweight (BMI of 25 - 29.9 kg/m\^2);
  18. * Owns a cell phone capable of receiving text messages;
  19. * Agrees to be audio recorded
  20. * Self-Identifies as Hispanic/Latino
  21. * Seeking services at the VDS (or has used VDS services in the past) of the Mexican - Consulate or VDS Mobile
  22. * Prefers to speak in Spanish
  23. * At least 18 years of age
  24. * Has at least one child under age 18 living in the same household
  25. * Owns a cell phone capable of receiving text messages
  26. * Willing to receive text messages (3 texts per week for 3 months)
  27. * Owns an internet connected device (eg, cell phone, tablet, etc) capable of conducting teleconference calls (eg, Zoom)
  28. * At least 21 years of age
  29. * Full-time (drives at least 35 hours per week) licensed taxi/FHV driver
  30. * Driver for at least 6 months
  31. * Seeking Health Fairs (or has used Health Fairs services in the past)
  32. * Speaks English, French, Bengali, or Spanish
  33. * Screens a as obese (BMI ≥ 30 kg/m2 \[≥25 kg/m2 for South Asians\]) or overweight (BMI of 25 - 29.9 kg/m2 s \[23- 24.9 kg/m2 for South Asians\])
  34. * (BMI cut-offs are lower for South Asians, per WHO and American Diabetes Association recommendations)
  35. * Owns a cell phone capable of receiving text messages
  36. * Agrees to be audio-recorded
  37. * At least 21 years of age
  38. * Driver who participated in ROADmAP RCT or manager at a taxi garage, Uber, Lyft or driver serving/union/organization
  39. * Agrees to be audio-recorded
  1. * Will not be in the NYC area for the study duration (3-4 months) Is pregnant or might be pregnant
  2. * Lactating women
  3. * Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study)
  4. * Has dietary restrictions (i.e. liquid diet)
  5. * Does not have a phone that accepts text messages or unwilling to accept text messages
  6. * Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional"s judgment
  7. * Has another family member already enrolled in COMIDA (as determined by patient report)
  8. * Is pregnant or might be pregnant; lactating women;
  9. * Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate);
  10. * Has dietary restrictions (i.e. liquid diet);
  11. * Has a household member who has already participated (or agreed to participate);
  12. * Is pregnant or might be pregnant; lactating women; for the study duration (6 months)
  13. * Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate); restricting diet;
  14. * Currently has dietary restrictions (i.e. liquid diet);
  15. * Has a household member who has already participated (or agreed to participate);
  16. * Has already participated in the study
  17. * Will not be in the NY Metropolitan area for the study duration (6 months) Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services)
  18. * Is pregnant or might be pregnant; lactating women for the study duration (3 months)
  19. * Will not be in the NY Metropolitan area for the study duration (3 months) Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study)
  20. * Has dietary restrictions (i.e. liquid diet)
  21. * Has another family member who has already participated in COMIDA or SANOS
  22. * Has already participated in the study
  23. * Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services)
  24. * Is pregnant or might be pregnant; lactating women; for the study duration (12 months)
  25. * Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate) that may restrict diet
  26. * Currently has dietary restrictions (i.e. liquid diet)
  27. * Has a household member who has already participated (or agreed to participate)
  28. * Has already participated in the study
  29. * Will not be in the NY Metropolitan area for 6 months from study enrollment
  30. * Is currently taking Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity Saxenda, Victoza, Phentermine (Adipex, Lomaira), Extended-release Phentermine/Topiramate (Qsymia), Extended-release Naltrexone/Bupropion (Contrave), Plenity, Orlistat (Xenical) or Other GLP-1 receptor agonist, or any other drug to treat obesity or there is less than 7 weeks since last dosage.
  31. * Has undergone weight loss/bariatric surgery or is planning to undergo such surgery in the next 12 months.

Contacts and Locations

Study Contact

Jennifer Leng, MD,MPH
CONTACT
646-888-8057
lengj@mskcc.org
Francesca Gany, MD, MS
CONTACT
646-888-8054

Principal Investigator

Jennifer Leng, MD, MPH
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Mexican Consulate's Ventanilla de Salud (VDS)
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Jennifer Leng, MD, MPH, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-12-22
Study Completion Date2026-08-11

Study Record Updates

Study Start Date2022-12-22
Study Completion Date2026-08-11

Terms related to this study

Keywords Provided by Researchers

  • Focus Groups
  • Overweight
  • Overweight and Obesity
  • Overweight or Obesity
  • Obesity
  • Obese
  • Memorial Sloan Kettering Cancer Center

Additional Relevant MeSH Terms

  • Overweight
  • Overweight and Obesity
  • Overweight or Obesity
  • Obesity
  • Obese